GOALS OF WORK: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. PATIENTS AND METHODS: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. MAIN RESULTS: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). CONCLUSION: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.
GOALS OF WORK: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. PATIENTS AND METHODS: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. MAIN RESULTS: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). CONCLUSION: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.
Authors: Elaine Bannerman; Michelle D Miller; Lynne A Daniels; Lynne Cobiac; Lynne C Giles; Craig Whitehead; Gary R Andrews; Maria Crotty Journal: Public Health Nutr Date: 2002-10 Impact factor: 4.022
Authors: A S Detsky; J R McLaughlin; J P Baker; N Johnston; S Whittaker; R A Mendelson; K N Jeejeebhoy Journal: JPEN J Parenter Enteral Nutr Date: 1987 Jan-Feb Impact factor: 4.016
Authors: Mary E Platek; Elizabeth Myrick; Susan A McCloskey; Vishal Gupta; Mary E Reid; Gregory E Wilding; David Cohan; Hassan Arshad; Nestor R Rigual; Wesley L Hicks; Maureen Sullivan; Graham W Warren; Anurag K Singh Journal: Support Care Cancer Date: 2013-06-07 Impact factor: 3.603
Authors: Mary E Platek; Johann V Popp; Candi S Possinger; Carol A Denysschen; Peter Horvath; Jean K Brown Journal: Cancer Nurs Date: 2011 Sep-Oct Impact factor: 2.592
Authors: Clare Shaw; Catherine Fleuret; Jennifer M Pickard; Kabir Mohammed; Gayle Black; Linda Wedlake Journal: Support Care Cancer Date: 2014-06-20 Impact factor: 3.603
Authors: Chelsia Gillis; Leslee Hasil; Popi Kasvis; Neil Bibby; Sarah J Davies; Carla M Prado; Malcolm A West; Clare Shaw Journal: Front Nutr Date: 2021-06-24